Connective-tissue effects of drugs causing lupoid syndrome.
D000818:Animals; D002250:Carbon Radioisotopes; D002642:Chick Embryo; D002746:Chlorpromazine / Q000494:pharmacology*; D003094:Collagen / Q000096:biosynthesis*; D003864:Depression, Chemical; D005944:Glucosamine / Q000378:metabolism; D006830:Hydralazine / Q000494:pharmacology*; D006900:Hydroxylation; D006901:Hydroxylysine / Q000096:biosynthesis; D006909:Hydroxyproline / Q000096:biosynthesis; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008239:Lysine / Q000378:metabolism; D009088:Mucoproteins / Q000096:biosynthesis*; D011342:Procainamide / Q000494:pharmacology*; D011392:Proline / Q000378:metabolism; D013977:Tibia / Q000187:drug effects
D002250:Carbon Radioisotopes; D009088:Mucoproteins; D006830:Hydralazine; D006901:Hydroxylysine; D003094:Collagen; D011392:Proline; D008239:Lysine; D011342:Procainamide; D005944:Glucosamine; D006909:Hydroxyproline; D002746:Chlorpromazine